Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thyrogen stimulation and gut microbiome study in subclinical autoimmune hypothyroidism
NL-OMON49953Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of thyrotropin alfa in autoimmune thyroiditis, Hashimoto's disease and hypothyroidism (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Residual thyroid function difference between SCT and healthy controls. Started Dec 2020; status: active, not recruiting.
02
Drugs
thyrotropin alfa
03
Conditions
autoimmune thyroiditisHashimoto's diseasehypothyroidism
Beyond the preview
Go deeper on NL-OMON49953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49953.